Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EBIT (2016 - 2025)

Historic EBIT for INVO Fertility (IVF) over the last 17 years, with Q3 2025 value amounting to -$1.6 million.

  • INVO Fertility's EBIT fell 2576.76% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.2 million, marking a year-over-year decrease of 30839.32%. This contributed to the annual value of -$8.1 million for FY2024, which is 2007.26% down from last year.
  • According to the latest figures from Q3 2025, INVO Fertility's EBIT is -$1.6 million, which was down 2576.76% from -$3.0 million recorded in Q2 2025.
  • Over the past 5 years, INVO Fertility's EBIT peaked at $503555.0 during Q4 2021, and registered a low of -$17.1 million during Q1 2025.
  • Moreover, its 5-year median value for EBIT was -$2.1 million (2023), whereas its average is -$2.8 million.
  • Per our database at Business Quant, INVO Fertility's EBIT surged by 12816.69% in 2021 and then tumbled by 103441.59% in 2025.
  • INVO Fertility's EBIT (Quarter) stood at $503555.0 in 2021, then plummeted by 639.82% to -$2.7 million in 2022, then surged by 44.51% to -$1.5 million in 2023, then crashed by 129.65% to -$3.5 million in 2024, then surged by 52.79% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, -$3.0 million for Q2 2025, and -$17.1 million during Q1 2025.